Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bearish
2
Neutral
9
Bullish
3
Bearish
33
Neutral
9
Bullish
4
Bearish
31
Neutral
0
Bullish
1
Investor Presentation
Q4 FY25
Investor Presentation
Q2 FY24
Investor Presentation
Q2 FY23
Investor Presentation
Q4 FY18

Market Cap
₹ 9,422 Cr
P/E
30.71
Pharmaceuticals
Pharmaceuticals - Multinational
9,422 Cr
Low Risk
30.7
41.4
3.1
15.2
6,700.00
4,916.00
Sales CAGR
1Y
-18.86%
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
—
3Y
—
5Y
—
10Y
—
ROE
TTM
49.51%
3Y
43.66%
5Y
43.66%
10Y
43.66%
ROCE
TTM
65.17%
3Y
53.90%
5Y
53.90%
10Y
53.90%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
LOW RISK